With hopes of making one dose of an inactivated H7N9 vaccine fully protective, scientists successfully tested a prime-boost concept in a small clinical trial. The ‘primer’ vaccine introduces the immune system to H7N9 influenza virus, and subsequent vaccination with the ‘booster’ inactivated virus vaccine promotes a better immune response.